Skip to main content
. 2003 Nov;41(11):4915–4923. doi: 10.1128/JCM.41.11.4915-4923.2003

TABLE 3.

Comparison of methods for the diagnosis of respiratory M. pneumoniae infection

Reference Specimen(s)a No. of patients Subject age rangeb No. (%) of samples positive by detection methodc:
PCR Culture CF DAG Serology
1 NA, TA 190 3-66 20 (10.5) 8 (4.2) ND 11 (5.8) 17 (8.9)
4 TS 99 <1-81 49 (49.5)f ND ND ND 32 (32.3)
8 TS 21 2-18 11 (52.4) ND ND ND 13 (61.9)
10 BAL, BA, Sp 163 1-81 13 (8.0) 9 (5.5) ND ND ND
11 BAL, TS 75 NS 6 (8.0) ND ND ND ND
13 TS, BAL, BA, SP, NSw 144 20-93 15/18 (10.4) ND 10/18 (6.9) ND 4/18 (2.8)
14 TS 305 NS 12 (3.9) ND ND ND ND
15 TS 92 NS 7/9 (7.6) 6/9 (6.5) 7/9 (7.6) ND 7/9 (7.6)
17 TNA 93 NS 8 (8.6) ND ND ND 18 (19.3)
20 NA 132 3m-14y 3 (2.3) ND ND ND ND
25 NSw, TS 66 NS 7 (10.6) ND ND ND ND
28 NA 1,118 NS 91 (8.1) ND ND ND ND
26d RPA, TA 165 2-15 22 (13.3) 13 (7.9) 5 (3.0) ND 12 (7.3)
30 NA 115 6m-29m 30 (26) ND ND ND ND
31 NA, TS 48 <1-16 31 (64.5) ND ND ND 23 (47.9)
34 TS, BAL, Sp 197 NS 25/34 (12.7) ND ND ND 31/34 (15.7)
36 NA 371 <1-16 13 (3.5) 8 (2.2) ND ND ND
39 TS 105 NS 27/31 (25.7) 31 (29.5) ND ND ND
40 BAL 116 1-80 12 (10.3) 7 (6.0) 12 (10.3) ND ND
41 TS 63 21-62 9 (14.3) ND ND ND ND
45 NSw 3,897 NS 283 (7.3) ND ND ND ND
48 TS 102 NS 35 (34.3) 21 (20.5) 40 (39.2) ND ND
49 TS, Sp 316 NS 0 (0) ND ND ND 23 (7.3)
50 NSw, TS 557 0-94 7 (1.3) ND ND ND ND
51 TS, Sp 184 NS 3 (1.6) ND ND ND 2 (1.1)
57 TS 155 7-92 8 (5.2) ND ND ND 9 (5.8)
62 NA, BAL 100 <1-16 20 (20) 1 (1) 5 (5) ND ND
66 BAL 103 NS 2 (1.9)f ND ND ND ND
67 Sp, TS, NSw, BAL, NA 79 <1-85 9/14 (11.4) 2/14 (2.5) 9/14 (11.4)j ND 9/14 (11.4)
68 TS, NSw 462 0-16 11 (2.4) ND ND ND ND
69 Sp 244 5-95 7 (2.9) ND ND ND ND
74 Sp 34 NS 9/10 (26.5) 7/10 (20.1) ND ND 9/10 (26.5)
76 TS 473 15-65 4 (0.8)g 2 (0.6)h ND ND 2/4
78 TS 280 NS 73 (26.1) 22 (7.9)i ND ND ND
79e NA 278 <1-16.5 10 (3.6) 8 (2.9) ND ND 31 (11.2)
83 TS, NSw 168 <1-16 5 (3.0) 5 (3.0) ND ND 10 (6.0)
a

Abbreviations: BAL, bronchoalveolar lavage; NA, nasopharyngeal aspirate; NSw, nasal swab; PS, pharyngeal swab; RPA, rhinopharyngeal aspirate; Sp, sputum; TA, tracheal aspirate; TNA, transthoracic needle aspiration; TS, throat swab.

b

Age ranges given in years (y) unless specified otherwise. m, months; NS, not specified.

c

Abbreviations: CF, complement fixation test; DAG, direct antigen test; ND, not done.

d

Twenty PCR-positive specimens were cultured, but complement fixation and IgM serology were not done for all patients.

e

PCR and culture were not done for all patients.

f

Results confirmed by another PCR targeting another region of the P1 gene.

g

Two of four nasopharyngeal aspirates were PCR positive.

h

Two of 350 throat swab specimens were culture positive.

i

Culture was done for a selection of 108 of 280 specimens.

j

Done for 59 of 79 patients.